HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Bacterial Protein CNF1 as a Potential Therapeutic Strategy against Mitochondrial Diseases: A Pilot Study.

Abstract
The Escherichia coli protein toxin cytotoxic necrotizing factor 1 (CNF1), which acts on the Rho GTPases that are key regulators of the actin cytoskeleton, is emerging as a potential therapeutic tool against certain neurological diseases characterized by cellular energy homeostasis impairment. In this brief communication, we show explorative results on the toxin’s effect on fibroblasts derived from a patient affected by myoclonic epilepsy with ragged-red fibers (MERRF) that carries a mutation in the m.8344A>G gene of mitochondrial DNA. We found that, in the patient’s cells, besides rescuing the wild-type-like mitochondrial morphology, CNF1 administration is able to trigger a significant increase in cellular content of ATP and of the mitochondrial outer membrane marker Tom20. These results were accompanied by a profound F-actin reorganization in MERRF fibroblasts, which is a typical CNF1-induced effect on cell cytoskeleton. These results point at a possible role of the actin organization in preventing or limiting the cell damage due to mitochondrial impairment and at CNF1 treatment as a possible novel strategy against mitochondrial diseases still without cure.
AuthorsAlessia Fabbri, Sara Travaglione, Zaira Maroccia, Marco Guidotti, Ciro Leonardo Pierri, Guido Primiano, Serenella Servidei, Stefano Loizzo, Carla Fiorentini
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 19 Issue 7 (06 21 2018) ISSN: 1422-0067 [Electronic] Switzerland
PMID29933571 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Bacterial Toxins
  • DNA, Mitochondrial
  • Escherichia coli Proteins
  • Membrane Transport Proteins
  • Mitochondrial Precursor Protein Import Complex Proteins
  • Receptors, Cell Surface
  • TOMM20 protein, human
  • cytotoxic necrotizing factor type 1
  • Adenosine Triphosphate
  • Electron Transport Complex IV
Topics
  • Adenosine Triphosphate (biosynthesis)
  • Bacterial Toxins (isolation & purification, pharmacology)
  • DNA, Mitochondrial (genetics, metabolism)
  • Electron Transport Complex IV (genetics, metabolism)
  • Escherichia coli (chemistry)
  • Escherichia coli Proteins (isolation & purification, pharmacology)
  • Fibroblasts (drug effects, metabolism, pathology)
  • Gene Expression
  • Humans
  • MERRF Syndrome (drug therapy, genetics, metabolism, pathology)
  • Male
  • Membrane Transport Proteins (genetics, metabolism)
  • Middle Aged
  • Mitochondria (drug effects, genetics, metabolism, ultrastructure)
  • Mitochondrial Precursor Protein Import Complex Proteins
  • Mutation
  • Pilot Projects
  • Primary Cell Culture
  • Receptors, Cell Surface (genetics, metabolism)
  • Stress Fibers (drug effects, metabolism, ultrastructure)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: